Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies

Abstract

Ischemia-reperfusion (I/R) injury is accompanied with high morbidity and mortality and has seriously negative social and economic influences. Unfortunately, few effective therapeutic strategies are available to improve its outcome. Berberine is a natural medicine possessing multiple beneficial biological activities. Emerging evidence indicates that berberine has potential protective effects against I/R injury in brain, heart, kidney, liver, intestine and testis. However, up-to-date review focusing on the beneficial role of berberine against I/R injury is not yet available. In this paper, results from animal models and clinical studies are concisely presented and its mechanisms are discussed. We found that berberine ameliorates I/R injury in animal models via its anti-oxidant, anti-apoptotic and anti-inflammatory effects. Moreover, berberine also attenuates I/R injury by suppressing endoplasmic reticulum stress and promoting autophagy. Additionally, regulation of periphery immune system may also contributes to the beneficial effect of berberine against I/R injury. Although clinical evidence is limited, the current studies indicate that berberine may attenuate I/R injury via inhibiting excessive inflammatory response in patients. Collectively, berberine might be used as an alternative therapeutic strategy for the management of I/R injury.

Keywords: AG490 (PubChem CID: 5328779); Apoptosis; Autophagy; Berberine; Berberine (PubChem CID: 2353); Glycyrrhizin (PubChem CID: 14982); Inflammatory response; Ischemia-reperfusion injury; LY294002 (PubChem CID: 3973); Malondialdehyde (PubChem CID: 10964); Nitric oxide (PubChem CID: 145068); Oxidative stress.